Carta científico-clínica
Pigmentación oral asociada al tratamiento con alfa-interferón y ribavirina para la hepatitis C
Oral Hyperpigmentation Associated With Interferon-Alpha and Ribavirin Therapy for Hepatitis C Virus Infection
J. Marcoval
, J. Notario, C. Martín, S. Gómez
Autor para correspondencia
Servicio de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, España
Leído
8420
Vecesse ha leído el artículo
2503
Total PDF
5917
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 159 | 24 | 183 |
| 2025 5 | 122 | 33 | 155 |
| 2025 4 | 111 | 27 | 138 |
| 2025 3 | 102 | 18 | 120 |
| 2025 2 | 105 | 37 | 142 |
| 2025 1 | 75 | 30 | 105 |
| 2024 12 | 83 | 26 | 109 |
| 2024 11 | 87 | 65 | 152 |
| 2024 10 | 37 | 32 | 69 |
| 2024 9 | 52 | 31 | 83 |
| 2024 8 | 76 | 63 | 139 |
| 2024 7 | 65 | 41 | 106 |
| 2024 6 | 65 | 39 | 104 |
| 2024 5 | 51 | 50 | 101 |
| 2024 4 | 65 | 30 | 95 |
| 2024 3 | 54 | 30 | 84 |
| 2024 2 | 65 | 24 | 89 |
| 2024 1 | 49 | 22 | 71 |
| 2023 12 | 57 | 12 | 69 |
| 2023 11 | 75 | 30 | 105 |
| 2023 10 | 55 | 24 | 79 |
| 2023 9 | 49 | 17 | 66 |
| 2023 8 | 50 | 17 | 67 |
| 2023 7 | 87 | 30 | 117 |
| 2023 6 | 63 | 18 | 81 |
| 2023 5 | 79 | 35 | 114 |
| 2023 4 | 65 | 22 | 87 |
| 2023 3 | 56 | 20 | 76 |
| 2023 2 | 73 | 32 | 105 |
| 2022 1 | 53 | 18 | 71 |
| 2022 12 | 62 | 21 | 83 |
| 2022 11 | 80 | 41 | 121 |
| 2022 10 | 66 | 30 | 96 |
| 2022 9 | 61 | 68 | 129 |
| 2022 8 | 49 | 69 | 118 |
| 2022 7 | 48 | 45 | 93 |
| 2022 6 | 55 | 45 | 100 |
| 2022 5 | 91 | 35 | 126 |
| 2022 4 | 61 | 36 | 97 |
| 2022 3 | 51 | 46 | 97 |
| 2022 2 | 63 | 24 | 87 |
| 2021 1 | 58 | 36 | 94 |
| 2021 12 | 56 | 38 | 94 |
| 2021 11 | 70 | 44 | 114 |
| 2021 10 | 78 | 37 | 115 |
| 2021 9 | 64 | 44 | 108 |
| 2021 8 | 60 | 20 | 80 |
| 2021 7 | 47 | 24 | 71 |
| 2021 6 | 42 | 29 | 71 |
| 2021 5 | 44 | 30 | 74 |
| 2021 4 | 84 | 52 | 136 |
| 2021 3 | 112 | 31 | 143 |
| 2021 2 | 61 | 21 | 82 |
| 2020 1 | 43 | 17 | 60 |
| 2020 12 | 26 | 19 | 45 |
| 2020 11 | 26 | 12 | 38 |
| 2020 10 | 34 | 26 | 60 |
| 2020 9 | 33 | 19 | 52 |
| 2020 8 | 23 | 19 | 42 |
| 2020 7 | 37 | 10 | 47 |
| 2020 6 | 30 | 17 | 47 |
| 2020 5 | 22 | 25 | 47 |
| 2020 4 | 37 | 20 | 57 |
| 2020 3 | 31 | 14 | 45 |
| 2020 2 | 3 | 1 | 4 |
| 2019 12 | 4 | 5 | 9 |
| 2019 11 | 0 | 2 | 2 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 5 | 1 | 6 |
| 2019 8 | 0 | 5 | 5 |
| 2019 7 | 0 | 5 | 5 |
| 2019 6 | 3 | 1 | 4 |
| 2019 5 | 3 | 7 | 10 |
| 2019 4 | 0 | 15 | 15 |
| 2019 3 | 2 | 16 | 18 |
| 2019 2 | 3 | 5 | 8 |
| 2019 1 | 1 | 5 | 6 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 0 | 10 | 10 |
| 2018 10 | 2 | 8 | 10 |
| 2018 9 | 4 | 5 | 9 |
| 2018 8 | 0 | 7 | 7 |
| 2018 7 | 0 | 4 | 4 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 0 | 3 | 3 |
| 2018 2 | 43 | 4 | 47 |
| 2018 1 | 47 | 5 | 52 |
| 2017 12 | 51 | 7 | 58 |
| 2017 11 | 44 | 13 | 57 |
| 2017 10 | 52 | 15 | 67 |
| 2017 9 | 68 | 11 | 79 |
| 2017 8 | 49 | 16 | 65 |
| 2017 7 | 42 | 9 | 51 |
| 2017 6 | 57 | 15 | 72 |
| 2017 5 | 66 | 9 | 75 |
| 2017 4 | 56 | 9 | 65 |
| 2017 3 | 38 | 25 | 63 |
| 2017 2 | 99 | 12 | 111 |
| 2016 1 | 31 | 15 | 46 |
| 2016 12 | 42 | 5 | 47 |
| 2016 11 | 72 | 17 | 89 |
| 2016 10 | 88 | 11 | 99 |
| 2016 9 | 124 | 22 | 146 |
| 2016 8 | 42 | 13 | 55 |
| 2016 7 | 33 | 6 | 39 |
| 2016 6 | 23 | 13 | 36 |
| 2016 5 | 7 | 11 | 18 |
| 2016 4 | 8 | 3 | 11 |
| 2016 3 | 10 | 1 | 11 |
| 2016 2 | 4 | 3 | 7 |
| 2015 1 | 10 | 14 | 24 |
| 2015 12 | 10 | 4 | 14 |
| 2015 11 | 5 | 2 | 7 |
| 2015 10 | 4 | 6 | 10 |
| 2015 9 | 7 | 3 | 10 |
| 2015 8 | 6 | 1 | 7 |
| 2015 7 | 45 | 9 | 54 |
| 2015 6 | 47 | 2 | 49 |
| 2015 5 | 51 | 6 | 57 |
| 2015 4 | 44 | 7 | 51 |
| 2015 3 | 35 | 4 | 39 |
| 2015 2 | 49 | 9 | 58 |
| 2015 1 | 48 | 13 | 61 |
| 2014 12 | 53 | 10 | 63 |
| 2014 11 | 33 | 9 | 42 |
| 2014 10 | 56 | 7 | 63 |
| 2014 9 | 38 | 12 | 50 |
| 2014 8 | 31 | 4 | 35 |
| 2014 7 | 31 | 8 | 39 |
| 2014 6 | 28 | 8 | 36 |
| 2014 5 | 34 | 7 | 41 |
| 2014 4 | 21 | 3 | 24 |
| 2014 3 | 14 | 9 | 23 |
Mostrar todo
